4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001702626-22-000002
Options or other derivatives
- CEO & President acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Equels Thomas K CEO & President | 2022-03-03 | Grant or award · Options | +50,000 | 50,000 | D: show line 1 in the form |
Loading xslF345X03/primary_doc.xml…